Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
182,917,028
Total 13F shares
120,246,621
Share change
+18,866,828
Total reported value
$986,101,781
Put/Call ratio
110%
Price per share
$8.20
Number of holders
160
Value change
+$176,011,863
Number of buys
91
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q3 2024

As of 30 Sep 2024, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 120,246,621 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., MAVERICK CAPITAL LTD, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., M28 Capital Management LP, Driehaus Capital Management LLC, Siren, L.L.C., Kynam Capital Management, LP, 683 Capital Management, LLC, and Bellevue Group AG. This page lists 160 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.